Patient Leaflet Updated 29-Aug-2023 | hameln pharma ltd
Ergometrine Injection BP 0.05% w/v
Ergometrine Injection
ergometrine maleate
1. What Ergometrine Injection is and what it is used for
2. What you need to know before you are given Ergometrine Injection
3. How Ergometrine Injection is given
4. Possible side effects
5. How to store Ergometrine Injection
6. Contents of the pack and other information
Ergometrine Injection is a medicine that causes contraction of the muscles of the womb and is used:
Talk to your doctor, pharmacist or nurse before being given the injection:
If any of the above applies to you, or you are not sure, speak to your doctor or nurse before you receive Ergometrine Injection.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
This is especially important with the following medicines as they may interact with your Ergometrine Injection:
Tell your doctor or midwife if you have recently had any grapefruit juice. It is recommended that you do not drink grapefruit juice around the same time as your treatment with Ergometrine Injection as these may interact.
Pregnancy
You must not receive Ergometrine Injection if you are pregnant or if you are in labour but the baby’s shoulder still cannot be seen.
If your baby is in a breech position (or any other abnormal position) before birth, Ergometrine Injection will not be given until after your baby has been born.
If you have a multiple pregnancy (e.g. twins, triplets), Ergometrine Injection will not be given until after the last baby has been born.
Breast-feeding
Ergometrine may reduce milk production, therefore repeated use should be avoided.
Ergometrine can start labour. Women with contractions should not drive or use machines. Ergometrine can cause the side effects of dizziness and low blood pressure (symptoms of which are light-headedness and blurred vision) in some people. If affected you should not drive or use machinery.
Your nurse or doctor will give you the injection.
Your doctor will decide the correct dosage for you and how and when the injection will be given.
Since the injection will be given to you by a doctor or nurse, it is unlikely that you will be given too much.
If you think you have been given too much or if you experience any of the following effects you must tell the person giving you the injection immediately.
Ergometrine Injection is not recommended for elderly patients and children.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you get any side effects, talk to your doctor, pharmacist or nurse: This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme – Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Your injection will be stored in a refrigerator between 2°C to 8°C and protected from light.
Storage out of the refrigerator:
Ergometrine Injection may also be stored outside of the refrigerator at a temperature of up to 25°C for a maximum 12 weeks, after which it should be discarded. The product should not be placed back into the refrigerator, once it has been kept outside. The storage period must not exceed the shelf-life.
Do not use this medicine after the expiry date which is stated on the label and carton. The expiry date refers to the last day of that month.
The active ingredient is ergometrine maleate 0.05% w.v. Each 1 ml of solution contains 500 micrograms of ergometrine maleate.
The other ingredients are maleic acid and sterile water for injections.
Ergometrine Injection is supplied in a 1 ml clear glass ampoule, 10 ampoules are supplied in a carton.
The marketing authorisation number of this medicine is: PL 01502/0008R
For any information about this medicine, please contact the Marketing Authorisation Holder
This leaflet was last revised in November 2022.
44173/44/22
Nexus, Gloucester Business Park, Gloucester, GL3 4AG, UK
+44 (0)1452 621 661
https://www.hameln-pharma.com
+44 (0)1452 632 732